<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03049085</url>
  </required_header>
  <id_info>
    <org_study_id>Preoperative aspirin-OPCAB</org_study_id>
    <nct_id>NCT03049085</nct_id>
  </id_info>
  <brief_title>Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting</brief_title>
  <official_title>Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting: A Double-blind, Placebo-controlled, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medinet Heart Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medinet Heart Centre</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of Preoperative Aspirin in patients undergoing Off-pump Coronary Artery Bypass
      Grafting. A double-blind, placebo-controlled, randomized trial.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>6 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by Troponin T (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>12 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by Troponin T (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>24 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by Troponin T (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>72 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by Troponin T (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammation</measure>
    <time_frame>6 hours following OPCAB</time_frame>
    <description>Inflammation detected by CRP (mg/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammation</measure>
    <time_frame>12 hours following OPCAB</time_frame>
    <description>Inflammation detected by CRP (mg/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammation</measure>
    <time_frame>24 hours following OPCAB</time_frame>
    <description>Inflammation detected by CRP (mg/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammation</measure>
    <time_frame>72 hours following OPCAB</time_frame>
    <description>Inflammation detected by CRP (mg/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kidney Injury</measure>
    <time_frame>6 hours following OPCAB</time_frame>
    <description>Kidney injury detected by creatinine (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kidney Injury</measure>
    <time_frame>12 hours following OPCAB</time_frame>
    <description>Kidney injury detected by creatinine (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kidney Injury</measure>
    <time_frame>24 hours following OPCAB</time_frame>
    <description>Kidney injury detected by creatinine (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kidney Injury</measure>
    <time_frame>72 hours following OPCAB</time_frame>
    <description>Kidney injury detected by creatinine (mg/dl)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality or MACE up to 30 days after surgery</measure>
    <time_frame>30 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>6 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by CK-MB (U/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>12 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by CK-MB (U/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>24 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by CK-MB (U/l)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Injury</measure>
    <time_frame>72 hours following OPCAB</time_frame>
    <description>Myocardial injury detected by CK-MB (U/l)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative drainage (ml)</measure>
    <time_frame>12 hours and 24 hours following OPCAB</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding complication</measure>
    <time_frame>&lt; 30 days following OPCAB</time_frame>
    <description>reoperation for bleeding, cardiac tamponade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusions (units)</measure>
    <time_frame>&lt; 30 days following OPCAB</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Aspirin</condition>
  <arm_group>
    <arm_group_label>Aspirin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a 75 mg uncoated aspirin is administered 2 hours prior to OPCAB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>75 mg Vit. C is administered 2 hours prior OPCAB</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin</intervention_name>
    <description>preoperative uncoated 75 mg Aspirin is administered 2 hours prior OPCAB</description>
    <arm_group_label>Aspirin group</arm_group_label>
    <other_name>Acetylsalicylic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin C</intervention_name>
    <description>preoperative 75 mg Vit. C (Placebo) is administered 2 hours prior OPCAB</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible patients undergoing off-pump coronary artery bypass grafting (OPCAB)

          -  Patients in whom antiplatelet therapy was stopped 5-7 days prior to OPCAB

        Exclusion Criteria:

          -  Patients undergoing on-pump coronary artery bypass grafting

          -  Patients in whom antiplatelet therapy was not stopped 5-7 days prior to OPCAB

          -  Intraoperative conversion to on-pump coronary artery bypass grafting

          -  Patients with inherited blood-clotting disorders

          -  Patients undergoing other cardiac operations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medinet Heart Centre</name>
      <address>
        <city>Nowa Sol</city>
        <state>Lubuskie</state>
        <zip>67-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2017</study_first_submitted>
  <study_first_submitted_qc>February 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2017</study_first_posted>
  <last_update_submitted>February 7, 2017</last_update_submitted>
  <last_update_submitted_qc>February 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OPCAB</keyword>
  <keyword>ASA</keyword>
  <keyword>Aspirin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

